TFF Pharmaceuticals Plans Voluntary Delisting from Nasdaq and SEC Deregistration TFF Pharmaceuticals announced its intent to voluntarily delist from Nasdaq and potentially deregister with the SEC, marking a significant shift in its operations.

TFF Pharmaceuticals Plans Voluntary Delisting from Nasdaq and SEC Deregistration #United_States #TFF_Pharmaceuticals #SEC_Deregistration #Nasdaq_Delisting #Foxborough